Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma

Huichao Huang(Northeast Forestry University), Yongheng Chen(Hunan Cancer Hospital)
Pharmaceuticals
December 27, 2022
Cited by 84


Related Papers